Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
asset sale
Pharma
Galapagos sells its Jyseleca business to Italy's Alfasigma
Galapagos has agreed to sell its Jyseleca business to Alfasigma. Around 400 Galapagos employees will join the Italian company under the deal.
Kevin Dunleavy
Oct 31, 2023 9:10am
Glenmark addresses debt with $681M sale of API unit to Nirma
Sep 22, 2023 11:00am
Mirum ponies up $445M for 2 Travere liver disease drugs
Jul 18, 2023 8:00am
Stada buys another clutch of consumer health brands from Sanofi
Jul 12, 2023 9:01am
Bausch + Lomb scoops up Novartis' dry eye med Xiidra for $2.5B
Jun 30, 2023 10:05am
Lilly pawns off low blood sugar rescue med for $500M-plus
Apr 24, 2023 9:03am